CVRx, Inc. (CVRX)
NASDAQ: CVRX · Real-Time Price · USD
0.5010
-0.0319 (-5.99%)
At close: Nov 20, 2026, 4:00 PM EST
0.5012
+0.0002 (0.04%)
After-hours: Nov 20, 2026, 7:54 PM EST
CVRx, Inc. Revenue
CVRx, Inc. had revenue of $13.83M in the quarter ending September 30, 2026, a decrease of -5.84%. This brings the company's total for the last twelve months to $60.33M, up 7.79% year-over-year. In the year 2025, CVRx, Inc. had annual revenue of $56.65M with 10.45% growth. That makes CVRx, Inc. the 26,622nd largest company in the world by revenue and 3,637th in the United States.
Revenue (ttm)
$60.33M
Revenue Growth
+7.79%
P/S Ratio
0.24
Revenue / Employee
$270,538
Employees
223
Market Cap
14.27M
Revenue by Geography
- United States 51.88M 91.6%
- Europe 4.77M 8.4%
Fiscal year ended Dec 31, 2025 See the full CVRx, Inc. breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 56.65M | 5.36M | 10.45% |
| Dec 31, 2024 | 51.29M | 12.00M | 30.53% |
| Dec 31, 2023 | 39.30M | 16.83M | 74.89% |
| Dec 31, 2022 | 22.47M | 9.43M | 72.36% |
| Dec 31, 2021 | 13.04M | 6.98M | 115.36% |
| Dec 31, 2020 | 6.05M | -204.00K | -3.26% |
| Dec 31, 2019 | 6.26M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| SANUWAVE Health | 41.33M |
| Cytosorbents | 37.46M |
| QT Imaging Holdings | 29.58M |
| Lifeward | 21.06M |
| Nano-X Imaging | 15.63M |
| Pulsenmore | 14.13M |
| Picard Medical | 5.33M |
| Sintx Technologies | 3.31M |
CVRX News
- 2 days ago - What Does CVRx, Inc.'s 59.76% Stock Drop Mean for Investors? The Law Offices of Howard G. - PRNewsWire
- 2 days ago - CVRx, Inc. Transcript: Jefferies Global Healthcare Conference - Transcripts
- 3 days ago - What Should CVRx, Inc. Investors Know After 59.76% Stock Drop? The Law Offices of Frank R. - PRNewsWire
- 3 days ago - CVRx to Participate at the Piper Sandler 38th Annual Healthcare Conference - GlobeNewsWire
- 4 days ago - SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of January 8, 2027 in CVRx, Inc. Lawsuit - CVRX - GlobeNewsWire
- 10 days ago - CVRx, Inc. Transcript: Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum - Transcripts
- 15 days ago - CVRx price target lowered to $1.25 from $4 at Craig-Hallum - TheFly
- 15 days ago - CVRx price target lowered to $1.50 from $3.50 at Lake Street - TheFly